Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis.
Masaki HiroseAkiko MatsumuroToru AraiChikatoshi SugimotoMasanori AkiraMasanori KitaichiLisa R YoungFrancis X McCormackYoshikazu InouePublished in: PloS one (2019)
Serum VEGF-D is a useful diagnostic and therapeutic biomarker for LAM. Satisfactory precision and international inter-laboratory agreement of the clinical assay support VEGF-D recommendations in the ATS/JRS LAM Guidelines for the Japanese population.